Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02557477 | Omega 3/6 Fatty Acids for Reading in Children | ||
| NCT01820949 | Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients | ||
| NCT04616092 | Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT02232906 | Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) | ||
| NCT02213653 | Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT02221752 | Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | ||
| NCT01110356 | Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age | ||
| NCT02147795 | The German Patient Blood Management Network | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT01477424 | A Drug-Drug Interaction Study of Warfarin and PA21 | ||
| NCT03071263 | Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT05136664 | Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT05766839 | Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | ||
| NCT00994318 | Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) | ||
| NCT05897684 | Avacostar - (PASS) | ||
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | ||
| NCT01452906 | A Drug-Drug Interaction Study of Omeprazole and PA21 | ||
| NCT01464190 | A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi | ||
| NCT05885737 | Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus | ||
| NCT01477411 | A Drug-Drug Interaction Study of Digoxin and PA21 | ||
| NCT00978575 | Iron Substitution After Upper Gastro-Intestinal Bleeding | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT06256991 | Potassium Correction for RAAS Optimization in Chronic Kidney Disease | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT02687594 | Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) | ||
| NCT01101399 | Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy | ||
| NCT03644264 | PA21 Safety and Efficacy in Adult Chinese Subjects | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT01913808 | Comparing Intravenous and Oral Iron in Postoperative Anemia | ||
| NCT00824460 | Study of Phosphate Levels in Patients With Chronic Kidney Disease | ||
| NCT00868439 | Evaluation of Patiromer in Heart Failure Patients | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT05415969 | CKD-aP Among Adults on Dialysis in Switzerland | ||
| NCT01288651 | Iron Deficiency In Pulmonary Hypertension | ||
| NCT01371747 | Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT04510792 | IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors | ||
| NCT03759964 | Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery |
